Applied DNA Sciences Inc (APDN)
0.183
-0.01
(-6.78%)
USD |
NASDAQ |
Nov 04, 16:00
0.1823
0.00 (0.00%)
Pre-Market: 08:59
Applied DNA Sciences Shareholders Equity (Quarterly): 12.39M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 12.39M |
March 31, 2024 | -0.0481M |
December 31, 2023 | 4.232M |
September 30, 2023 | 4.951M |
June 30, 2023 | 7.249M |
March 31, 2023 | 10.01M |
December 31, 2022 | 9.162M |
September 30, 2022 | 12.91M |
June 30, 2022 | 6.796M |
March 31, 2022 | 7.648M |
December 31, 2021 | 8.392M |
September 30, 2021 | 11.11M |
June 30, 2021 | 15.59M |
March 31, 2021 | 18.63M |
December 31, 2020 | 5.729M |
September 30, 2020 | 5.718M |
June 30, 2020 | 8.785M |
March 31, 2020 | 7.275M |
December 31, 2019 | 7.231M |
September 30, 2019 | -0.8415M |
June 30, 2019 | -1.788M |
March 31, 2019 | -0.7344M |
December 31, 2018 | 0.766M |
September 30, 2018 | 0.7545M |
June 30, 2018 | 3.058M |
Date | Value |
---|---|
March 31, 2018 | 5.707M |
December 31, 2017 | 8.138M |
September 30, 2017 | 6.858M |
June 30, 2017 | 8.018M |
March 31, 2017 | 9.291M |
December 31, 2016 | 12.18M |
September 30, 2016 | 10.37M |
June 30, 2016 | 12.19M |
March 31, 2016 | 15.03M |
December 31, 2015 | 18.00M |
September 30, 2015 | 12.57M |
June 30, 2015 | 12.50M |
March 31, 2015 | 1.955M |
December 31, 2014 | 3.301M |
September 30, 2014 | -1.468M |
June 30, 2014 | 0.3112M |
March 31, 2014 | -0.3202M |
December 31, 2013 | 1.882M |
September 30, 2013 | 4.616M |
June 30, 2013 | 2.308M |
March 31, 2013 | -3.770M |
December 31, 2012 | -6.698M |
September 30, 2012 | 0.7569M |
June 30, 2012 | 1.316M |
March 31, 2012 | 0.8138M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.0481M
Minimum
Mar 2024
18.63M
Maximum
Mar 2021
8.619M
Average
7.648M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Fonar Corp | 165.97M |
XWELL Inc | 8.798M |
ProPhase Labs Inc | 44.08M |
Veracyte Inc | 1.133B |
OncoCyte Corp | 22.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 16.69M |
Total Liabilities (Quarterly) | 4.456M |
Current Ratio | 3.914 |